Scarica l'app Stockscreener
0.676
0.15%
0.001
Dopo l'orario di chiusura:
.66
-0.016
-2.37%
Biodexa Pharmaceuticals Plc Adr Borsa (BDRX) Ultime notizie
Biodexa Pharmaceuticals Plc (BDRX) Stock Price, News, Quote & History - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - CNN
BDRX Stock Pops As Phase 3 eRapa Momentum Builds - StocksToTrade
BDRX Stock Pops As Phase 3 eRapa Trial Crosses Key Milestone - timothysykes.com
BDRX Stock Draws Traders As Phase 3 Momentum Builds - StocksToTrade
BDRX Stock Jumps As Phase 3 Trial Momentum Builds - StocksToTrade
BDRX Stock Pops As Phase 3 Trial Momentum Builds - timothysykes.com
Biodexa Pharmaceuticals (NASDAQ: BDRX) Registers Resale of 3,403 ADSs by Selling Shareholders - Kalkine Media
Biodexa Pharmaceuticals Secures $3.5M in Funding, Anticipates Additional Q4 2026 Capital Needs (NASDAQ: BDRX) - Kalkine Media
Corning, Cellectis, Biodexa Pharmaceuticals And Other Big Stocks Moving Lower In Monday’s Pre-Market Sess - Benzinga
BDRX Jumps As Biodexa Advances Phase 3 eRapa Trial - StocksToTrade
Biodexa Pharmaceuticals PLC: Interim results for the six months ended June 30, 2026 - FinanzNachrichten.de
BDRX Stock Attracts Traders As Phase 3 Trial Crosses Key Milestone - StocksToTrade
Biodexa passes halfway mark in Phase 3 trial recruitment for FAP - Investing.com South Africa
Result of General Meeting - Yahoo Finance
Biodexa Pharmaceuticals plc (BDRX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Result of Annual General Meeting - Yahoo Finance UK
Biodexa prices $3.5 million offering with warrants - Investing.com
Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants - Yahoo Finance UK
Biodexa expands Serenta phase 3 trial into Canada By Investing.com - Investing.com India
Biodexa expands Serenta phase 3 trial into Canada - Investing.com
Biodexa Pharmaceuticals plc Sponsored ADR Actuals & Estimates (NASDAQ:BDRX) - TradingView
Postponement and Re-scheduling of Annual General Meeting - markets.businessinsider.com
BDRX News | BIODEXA PHARMACEUTICALS-ADR (NASDAQ:BDRX) - ChartMill
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
BeOne Medicines Ltd.Sponsored ADR (ONC) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
BDRXBiodexa Pharmaceuticals Plc ADR Latest SEC Filings - Finviz
BDRX Stock Price, Quote & Chart | BIODEXA PHARMACEUTICALS-ADR (NASDAQ:BDRX) - ChartMill
Biodexa proposes share capital reorganization at June meeting - Investing.com UK
Biodexa issues letter to Shareholders - markets.businessinsider.com
Biodexa proposes share capital reorganization at June meeting By Investing.com - Investing.com Nigeria
Biodexa plans to shrink 373B shares without cutting ADS stakes - Stock Titan
BDRX Stock Jumps As Biodexa ADRs Lead Biotech Rally - StocksToTrade
BDRX Stock Jumps As ADR Momentum Attracts Active Traders - timothysykes.com
Biodexa Pharmaceuticals surges on pre-market trading - Intellectia AI
Inventory turnover of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView — Track All Markets
What Makes Haleon PLC Sponsored ADR (HLN) a New Buy Stock - Yahoo Finance
Net income before discontinued operations of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView — Track All Markets
Book value per share of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView — Track All Markets
Biodexa Pharmaceuticals plc Sponsored ADR Cash Flow – FWB:5MP2 - TradingView — Track All Markets
Net debt of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView
Basic earnings per share (basic EPS) of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView
Price to earnings ratio of Biodexa Pharmaceuticals plc Sponsored ADR – FWB:5MP2 - TradingView
Who's Buying or Selling Biodexa Pharmaceuticals PLC (STU:5MP2) Stock Today? - GuruFocus
Biodexa Pharmaceuticals Plc: Shareholders Board Members Managers and Company Profile | US59564R8723 - marketscreener.com
Why Is Biodexa Pharmaceuticals (BDRX) Stock Skyrocketing Today? - Sahm
Why is Biodexa Pharmaceuticals (BDRX) stock skyrocketing today? - MSN
Biodexa partners with Syngene for MTX240 manufacturing By Investing.com - Investing.com Australia
171.7M Ordinary Shares resale prospectus — Biodexa (NASDAQ: BDRX) - Stock Titan
109.8M Ordinary Shares resale prospectus — Biodexa (NASDAQ: BDRX) - stocktitan.net
3.06%
2.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):